Are you Dr. Stark?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2594 Trailridge Dr E
Lafayette, CO 80026Phone+1 303-449-7740
Summary
- Dr. George Stark, MD is a urologist in Lafayette, Colorado. He is currently licensed to practice medicine in Colorado. He is affiliated with Rocky Mountain Regional VA Medical Center.
Education & Training
University of New Mexico School of MedicineResidency, Urology, 1983 - 1988
University of Colorado School of Medicine Anschutz Medical CampusClass of 1983
Certifications & Licensure
CO State Medical License 1988 - 2019
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2002
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 4791 citationsJak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteinsJames E. Darnell, Ian M. Kerr, George Stark Stark
Science. 1994-06-03 - 414 citationsComplex Modulation of Cell Type-Specific Signaling in Response to Type I InterferonsAnette H Van Boxel-Dezaire, M.R. Sandhya Rani, George Stark Stark
Immunity. 2006-09-01 - 116 citationsRegulation and mechanisms of mammalian gene amplification.George R. Stark
Advances in Cancer Research. 1993-01-01
Press Mentions
Biallelic JAK1 Mutations in Immunodeficient Patient with Mycobacterial InfectionApril 8th, 2016
N-lorem Foundation Founder and CEO, Stanley Crooke, M.D., Ph.D., Awarded the Steven C. Beering AwardSeptember 9th, 2023
Grant Support
- Signaling In Inflammation, Stress, And TumorigenesisNational Cancer Institute2011–2012
- Mechanisms And Functions Of Lysine Methylation Of Promoter-Bound NFKB And STAT3National Cancer Institute2011–2012
- Administrative CoreNational Cancer Institute2011–2012
- Activators And Repressors Of Nfkappab And Irf3/7 In Innate ImmunityNational Cancer Institute2008–2011
- Novel Essential Pathways For Ifn-Dependent Gene ExpressionNational Cancer Institute2005–2009
- Ifns And Cytokines: Signaling And ActionNational Cancer Institute2005–2009
- Negative Regulators Of NfkappabNational Cancer Institute2004–2007
- Novel Regulators Of P53 Accumulation And FunctionNational Institute Of General Medical Sciences2003–2006
- Ifns And Cytokines--Signaling And ActionNational Cancer Institute1999–2004
- Novel Regulators Of P53 Accumulation And FunctionNational Institute Of General Medical Sciences2003
- Negative Regulators Of NfkappabNational Cancer Institute2003
- Conference On Jaks &Stats: Activation &Biologic ImpactNational Cancer Institute2002
- P53 Modification And Novel Biological FunctionsNational Institute Of General Medical Sciences1999–2002
- Genetic Analysis Of Mammalian Signaling PathwaysNational Cancer Institute1999–2002
- Pathways Of Induction Of Functional P53 ProteinNational Institute Of General Medical Sciences1996–1999
- Genetic Analysis Of Interferon-Dependent SignalingNational Cancer Institute1997–1998
- Core--Tissue CultureNational Cancer Institute1997–1998
- Signaling Mechanisms In The Interferon SystemNational Cancer Institute1994–1998
- Mutant P53 Proteins Effects On Genomic StabilityFogarty International Center1995–1997
- Mechanisms &Regulation Of Mammalian Gene AmplificationNational Institute Of General Medical Sciences1993–1996
Professional Memberships
- Member
